XML 100 R21.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Executive Stock Plans And Stock-Based Compensation | 12 Months Ended
--- | ---
Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Executive Stock Plans And Stock-Based Compensation | EXECUTIVE STOCK PLANS AND STOCK-BASED COMPENSATION Executive Stock Plans The Company’s shareholders have approved executive stock plans under which officers, directors, and employees of the Company may receive grants and awards of common stock, restricted stock, restricted stock units (“RSUs”), performance share awards (“PSAs”), stock appreciation rights (“SARs”), incentive stock options, and non-qualified stock options. Currently, grants are outstanding under the 1997 Executive Stock Plan, the 2002 Executive Stock Plan, and the 2007 Stock Incentive Plan. Together, these plans are referred to in this disclosure as the “Plans.” Up to 2 million shares of the Company’s common stock may be issued under each of the Plans; however, direct awards of common stock, restricted stock, or RSUs are limited to 500,000 shares under the 2002 Executive Stock Plan and 1,350,000 shares under the 2007 Stock Incentive Plan. The Company’s practice is to award grants of stock-based compensation to officers at the first regularly-scheduled meeting of the Executive Compensation, Nominating, and Corporate Governance Committee of the Board of Directors (the “Compensation Committee”) in the fiscal year following the public release of the Company’s financial results for the prior year. Prior to 2006, non-qualified stock options were the primary form of stock-based compensation awarded, and some of those options remained outstanding at March 31, 2014. Since fiscal year 2006, grants have included restricted stock, RSUs, PSAs, and stock-settled SARs. In fiscal years 2013 and 2014, the Compensation Committee awarded only grants of RSUs and PSAs. Outside directors automatically receive restricted stock units following each annual meeting of shareholders. Non-qualified stock options and SARs granted under the Plans have an exercise price equal to the market price of a share of common stock on the date of grant. All stock options currently outstanding under the Plans are fully vested and exercisable, and they expire 10 years after the grant date. SARs granted under the Plans vest in equal one-third tranches one, two, and three years after the grant date and expire 10 years after the grant date, except that SARs granted after fiscal year 2007 expire on the earlier of 3 years after the grantee’s retirement date or 10 years after the grant date. RSUs awarded under the Plans vest 5 years from the grant date and are then paid out in shares of common stock. Under the terms of the RSU awards, grantees receive dividend equivalents in the form of additional RSUs that vest and are paid out on the same date as the original RSU grant. The PSAs vest 3 years from the grant date, are paid out in shares of common stock at the vesting date, and do not carry rights to dividends or dividend equivalents prior to vesting. Shares ultimately paid out under PSA grants are dependent on the achievement of predetermined performance measures established by the Compensation Committee and can range from zero to 150% of the stated award. RSUs awarded to outside directors vest 3 years after the grant date, and restricted stock vests upon the individual’s retirement from service as a director. Stock Options and SARs The following tables summarize the Company’s stock option and SAR activity and related information for fiscal years 2012 through 2014:
| Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Contractual Term (in years) |  | Aggregate Intrinsic Value
Fiscal Year Ended March 31, 2012: |  |  |  |  |  |  |
Outstanding at beginning of year | 922,598 |  |  | $ | 45.94 |  |  |  |  |
Granted | 170,400 |  |  | 37.86 |  |  |  |  |
Exercised | (195,948 | ) |  | 35.82 |  |  |  |  |
Cancelled/expired | (41,200 | ) |  | 59.25 |  |  |  |  |
Outstanding at end of year | 855,850 |  |  | 46.01 |  |  |  |  |
Fiscal Year Ended March 31, 2013: |  |  |  |  |  |  |
Exercised | (407,758 | ) |  | 41.21 |  |  |  |  |
Cancelled/expired | (29,615 | ) |  | 54.83 |  |  |  |  |
Outstanding at end of year | 418,477 |  |  | 50.07 |  |  |  |  |
Fiscal Year Ended March 31, 2014: |  |  |  |  |  |  |
Exercised | (161,137 | ) |  | 42.48 |  |  |  |  |
Outstanding at end of year | 257,340 |  |  | $ | 54.83 |  |  | 3.48 |  | $ | 1,418 |
Exercisable at end of year | 207,068 |  |  | $ | 58.95 |  |  | 2.58 |  | $ | 512 |
Expected to vest in future periods | 50,272 |  |  | $ | 37.86 |  |  | 7.20 |  | $ | 906 |
| Fiscal Year Ended March 31,
| 2014 |  | 2013 |  | 2012
Total intrinsic value of stock options and SARs exercised | $ | 2,816 |  |  | $ | 4,249 |  |  | $ | 1,745 |
Total fair value of SARs vested | $ | 769 |  |  | $ | 1,460 |  |  | $ | 1,713 |
Intrinsic value and aggregate intrinsic value in the tables above are based on the difference between the market price of the underlying shares at the exercise date or balance sheet date, as applicable, and the exercise prices of the stock options and SARs. The closing market prices used to determine the aggregate intrinsic value at the end of each fiscal year were as follows: $55.89 at March 31, 2014, $56.04 at March 31, 2013, and $46.60 at March 31, 2012. RSUs, Restricted Stock, and PSAs The following table summarizes the Company’s RSU, restricted stock, and PSA activity for fiscal years 2012 through 2014:
| RSUs |  | Restricted Stock |  | PSAs
| Shares |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value |  | Shares |  | Weighted-Average Grant Date Fair Value
Fiscal Year Ended March 31, 2012: |  |  |  |  |  |  |  |  |  |  |
Unvested at beginning of year | 246,816 |  |  | $ | 44.07 |  |  | 77,750 |  |  | $ | 40.77 |  |  | 131,419 |  |  | $ | 34.59 |
Granted | 84,290 |  |  | 38.28 |  |  | — |  |  | — |  |  | 57,383 |  |  | 35.56 |
Vested | (39,827 | ) |  | 35.94 |  |  | (10,350 | ) |  | 37.52 |  |  | (44,352 | ) |  | 45.96 |
Forfeited | — |  |  | — |  |  | — |  |  | — |  |  | (1,984 | ) |  | 33.30 |
Unvested at end of year | 291,279 |  |  | 43.72 |  |  | 67,400 |  |  | 41.91 |  |  | 142,466 |  |  | 31.45 |
Fiscal Year Ended March 31, 2013: |  |  |  |  |  |  |  |  |  |  |
Granted | 87,780 |  |  | 44.06 |  |  | — |  |  | — |  |  | 92,425 |  |  | 35.25 |
Vested | (86,925 | ) |  | 52.42 |  |  | (7,550 | ) |  | 43.74 |  |  | (94,725 | ) |  | 29.67 |
Forfeited | — |  |  | — |  |  | — |  |  | — |  |  | (5,149 | ) |  | 36.15 |
Unvested at end of year | 292,134 |  |  | 41.23 |  |  | 59,850 |  |  | 41.68 |  |  | 135,017 |  |  | 35.12 |
Fiscal Year Ended March 31, 2014: |  |  |  |  |  |  |  |  |  |  |
Granted | 70,092 |  |  | 57.79 |  |  | — |  |  | — |  |  | 52,400 |  |  | 53.56 |
Vested | (69,046 | ) |  | 44.89 |  |  | (11,750 | ) |  | 39.02 |  |  | (32,464 | ) |  | 33.95 |
Forfeited | — |  |  | — |  |  | — |  |  | — |  |  | (5,566 | ) |  | 37.45 |
Unvested at end of year | 293,180 |  |  | $ | 44.33 |  |  | 48,100 |  |  | $ | 42.33 |  |  | 149,387 |  |  | $ | 41.76 |
Shares granted and vested in the above table include dividend equivalents on RSUs and any shares awarded above the base grant under the performance provisions of PSAs. Shares forfeited or canceled include any reductions from the base PSA grant under those same performance provisions. Stock-Based Compensation Expense Determination of the Grant Date Fair Value of Stock-Based Compensation As indicated in the tables above, the Company granted RSUs and PSAs in each of fiscal years 2012 through 2014, and SARs in fiscal year 2012. The fair values of the RSUs and PSAs were based on the market price of the common stock on the grant date. The fair values of the SARs granted in fiscal year 2012 were estimated using the Black-Scholes pricing model and the following assumptions:
Assumptions: |  |
Expected term |  | 5.0 years
Expected volatility |  | 35.80%
Expected dividend yield |  | 5.07%
Risk-free interest rate |  | 1.66%
Resulting fair value of SARs granted |  | $7.46
The expected term was based on the Company’s historical exercise data for instruments with comparable features and economic characteristics. The expected volatility was estimated based on historical volatility of the Company’s common stock using weekly closing prices. The expected dividend yield was based on the annualized quarterly dividend rate and the market price of the common stock at grant date. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the grant date for securities with a remaining term equal to the expected term of the SARs. Since all SAR grants in fiscal year 2012 were awarded on the same date, the fair value shown in the above table represents the weighted-average grant date fair value for that year. Recognition of Compensation Expense Fair value expense for stock-based compensation is recognized ratably over the period from grant date to the earlier of (1) the vesting date of the award, or (2) the date the grantee is eligible to retire without forfeiting the award. For employees who are already eligible to retire at the date an award is granted, the total fair value of the award is recognized as expense at the date of grant. For the fiscal years ended March 31, 2014, 2013, and 2012, total stock-based compensation expense and the related income tax benefit recognized were as follows:
| Fiscal Year Ended March 31,
| 2014 |  | 2013 |  | 2012
Total stock-based compensation expense | $ | 6,278 |  |  | $ | 6,171 |  |  | $ | 5,987 |
Income tax benefit recorded on stock-based compensation expense | $ | 2,197 |  |  | $ | 2,160 |  |  | $ | 2,095 |
At March 31, 2014, the Company had $6.1 million of unrecognized compensation expense related to stock-based awards, which will be recognized over a weighted-average period of approximately 1.3 years. Cash proceeds from the exercise of stock options were $3.9 million for the fiscal year ended March 31, 2013, and were not material for the fiscal years ended March 31, 2014 or 2012.

X
- Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration